Apr 2023 $92 M No. 8 $50 to $250 million 13
Gynesonics, Inc.: Raise no. 8, Apr 2023 × Investors in this round 13 investors had bought by the notice of Nov 6, 2023: 13 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $92 M of $92 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Louis Baldino · Executive Officer, Director Robert Brown · Executive Officer Alexander Schmitz · Director David Pacitti · Director Greg Greifeld · Director Hugo Harrod · Director Joyce Erony · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “The amount sold includes $25,000,000 in converted debt.”Signed by "Louis ""Skip"" Baldino", Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Nov 6, 2023. Read the notice at the SEC .
equity SEC Dec 2021 $33 M No. 7 $10 to $50 million 18
Gynesonics, Inc.: Raise no. 7, Dec 2021 × Investors in this round 18 investors had bought by the notice of Dec 29, 2021: 18 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $33 M of $50 M offered; $18 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, other: Includes the issuance of shares of Series B, C, D, E, F, and F-1 Prime Preferred Stock and Series C Prime Preferred Warrants in exchange for Series A,B,C,D,E,F and F-1 Preferred Stock and Series C War Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Christopher Owens · Executive Officer, Director Jordan Bajor · Executive Officer Robert Brown · Executive Officer Chandra Leo · Director David Neustaedter · Director David Pacitti · Director Jeffrey Schwartz · Director Joyce Erony · Director Karen Talmadge · Director Mike Carusi · Director Robert O'Holla · Director Susan Stimson · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Includes the dollar amount from the conversion of the principal and interest of certain convertible notes.”Signed by Robert S. Brown, Chief Financial Officer. Source: SEC Form D, newest notice filed Dec 29, 2021. Read the notice at the SEC .
equity, options SEC Dec 2018 $75 M No. 6 $50 to $250 million 21
Gynesonics, Inc.: Raise no. 6, Dec 2018 × Investors in this round 21 investors had bought by the notice of Jan 3, 2019: 21 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $75 M of $77 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Christopher M. Owens · Executive Officer, Director Chandra M. Leo · Director David M. Neustaedter · Director Doug M. Fisher · Director Jeffrey M. Schwartz · Director Karen M. Talmadge · Director Ken M. Haas · Director Mike M. Carusi · Director Robert M. O'Holla · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Includes the dollar amount from the conversion of the principal and interest of certain convertible promissory notes.”On the use of proceeds: “Working capital and general corporate purposes.”Signed by Christopher M. Owens, President & CEO. Source: SEC Form D, newest notice filed Jan 3, 2019. Read the notice at the SEC .
equity SEC Jul 2015 $43 M No. 5 $10 to $50 million 16
Gynesonics, Inc.: Raise no. 5, Jul 2015 × Investors in this round 16 investors had bought by the notice of Jul 29, 2015: 16 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $43 M of $47 M offered; $4 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Christopher Owens · Executive Officer, Director Chandra P. Leo · Director Doug H. Fisher · Director Karen H. Talmadge · Director Ken Haas · Director Mike H. Carusi · Director Robert H. O'Holla · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Includes payment in cash and by the conversion of the principal and interest of certain notes.”On the use of proceeds: “The proceeds will be used for general corporate purposes.”Signed by Christopher M. Owens, Ceo. Source: SEC Form D, newest notice filed Jul 29, 2015. Read the notice at the SEC .
equity SEC Feb 2013 $28 M No. 4 $10 to $50 million 16
Gynesonics, Inc.: Raise no. 4, Feb 2013 × Investors in this round 16 investors had bought by the notice of Jul 9, 2014: 16 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $28 M of $35 M offered; $7 M still to sell
Smallest investment taken no minimum stated
What was sold equity, debt Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Christopher M. Owens · Executive Officer, Director Chandra P. Leo · Director Doug M. Fisher · Director Jonathan M. MacQuitty · Director Karen M. Talmadge · Director Ken M. Haas · Director Mike M. Carusi · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Christopher M. Owens, Ceo. Source: SEC Form D and 1 amendment, newest notice filed Jul 9, 2014. Read the notice at the SEC .
equity, debt SEC Feb 2012 $5 M No. 3 $2 to $10 million 8
Gynesonics, Inc.: Raise no. 3, Feb 2012 × Investors in this round 8 investors had bought by the notice of Feb 22, 2012: 8 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $7 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Darrin Uecker · Executive Officer, Director Doug Fisher · Director Jonathan MacQuitty · Director Karen Talmadge · Director Ken Haas · Director Tom Rodgers · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Darrin Uecker, Ceo. Source: SEC Form D, newest notice filed Feb 22, 2012. Read the notice at the SEC .
debt, options SEC May 2010 $16 M No. 2 $10 to $50 million 7
Gynesonics, Inc.: Raise no. 2, May 2010 × Investors in this round 7 investors had bought by the notice of Jul 30, 2010: 7 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $16 M of $21 M offered; $5 M still to sell
Smallest investment taken $5,000
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Darrin Uecker · Executive Officer, Director Jonathan McQuitty · Director Karen Talmadge · Director Ken Haas · Director Linda Grais · Director Tom Rodgers · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Jordan Bajor, Secretary. Source: SEC Form D and 1 amendment, newest notice filed Jul 30, 2010. Read the notice at the SEC .
equity SEC Nov 2009 $2 M No. 1 Under $2 million 7
Gynesonics, Inc.: Raise no. 1, Nov 2009 × Investors in this round 7 investors had bought by the notice of Nov 17, 2009: 7 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $3 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Darrin Uecker · Executive Officer, Director Jonathan McQuitty · Director Karen Talmadge · Director Ken Haas · Director Linda Grais · Director Tom Rodgers · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Jordan Bajor, Secretary. Source: SEC Form D, newest notice filed Nov 17, 2009. Read the notice at the SEC .
debt, options SEC